Viral Replication Cycles

Why This Matters

Understanding viral replication cycles is fundamental to nearly everything else you'll encounter in microbiology, from explaining why antibiotics don't work on viruses to predicting how pandemics spread. These cycles demonstrate core principles you're tested on: host-pathogen interactions, molecular mechanisms of infection, genetic transfer, and the strategies pathogens use to exploit cellular machinery. When you understand the "why" behind each step, you can predict viral behavior, explain drug targets, and connect individual viruses to their broader classification.

Don't just memorize the sequence of steps. Know what molecular event each stage represents and how variations in these cycles explain differences between virus types. Exam questions often ask you to compare lytic versus lysogenic cycles, explain why retroviruses are unique, or identify which stage a particular antiviral drug targets. Master the mechanisms, and you'll be ready for anything from multiple choice to complex FRQs.

---

Entry and Uncoating: Getting Inside the Host Cell

Before a virus can replicate, it must recognize, enter, and expose its genome within the host cell. These early steps determine host specificity and are prime targets for antiviral therapies.

Attachment

• Receptor-ligand binding determines host and tissue specificity. A virus can only infect cells that display its target receptor. For example, HIV binds the CD4 receptor (along with a CCR5 or CXCR4 coreceptor) on T-helper cells, which is why it specifically destroys that cell population.
• Viral attachment proteins (VAPs) on the virion surface interact with specific host receptors through protein-protein or protein-carbohydrate interactions.
• Host range is largely determined at this step. That's why rabies virus can infect many mammalian species (its receptor, the nicotinic acetylcholine receptor, is widely conserved), while other viruses are restricted to a single host or tissue type.

Penetration

Entry mechanism depends on whether the virus has an envelope:

• Enveloped viruses fuse their lipid envelope directly with a host membrane. This fusion can happen at the plasma membrane (pH-independent, as with HIV) or inside endosomes after acidification triggers conformational changes in fusion proteins (pH-dependent, as with influenza).
• Non-enveloped viruses typically enter through receptor-mediated endocytosis and then disrupt or penetrate the endosomal membrane to escape into the cytoplasm.
• The functional goal of penetration is delivering the genome to the correct cellular compartment for replication.

Uncoating

• Capsid disassembly releases the viral genome into the cytoplasm or nucleus, depending on where replication occurs.
• Timing varies by virus. Some uncoat immediately at the plasma membrane, while others require transport to specific organelles or the nucleus before disassembly.
• Uncoating signals often involve pH changes within endosomes, protease activity, or interactions with cellular chaperones.

---

Genome Replication and Protein Synthesis: Hijacking the Host

Once inside, viruses commandeer host machinery to copy their genomes and produce viral proteins. The replication strategy depends entirely on the type of nucleic acid the virus carries, which is the basis of the Baltimore classification system.

Replication

Genome type dictates strategy. The Baltimore system groups viruses into seven classes based on how they produce mRNA, and this is worth understanding rather than just memorizing:

• DNA viruses (Classes I and II) typically use host DNA polymerase and RNA polymerase in the nucleus. The major exception is poxviruses, which carry their own replication and transcription enzymes and replicate entirely in the cytoplasm.
• RNA viruses must solve a problem: host cells have no enzyme that copies RNA from an RNA template. So these viruses encode their own RNA-dependent RNA polymerase (RdRp).
  • Positive-sense ssRNA (Class IV, e.g., poliovirus) can be directly translated by host ribosomes as if it were mRNA, then RdRp is made to copy the genome.
  • Negative-sense ssRNA (Class V, e.g., influenza, Ebola) must first be transcribed into positive-sense mRNA by a viral RdRp that's packaged inside the virion.
  • dsRNA viruses (Class III, e.g., reoviruses) also carry RdRp within the virion to transcribe their genome.

The universal requirement across all classes: the virus must produce mRNA the host ribosome can translate. Everything else varies.

Location matters. Most DNA viruses replicate in the nucleus (where they can access host replication machinery), while most RNA viruses replicate in the cytoplasm (where ribosomes are and where they don't need nuclear import).

Retroviral Replication

Retroviruses (Class VI) have a unique strategy that deserves special attention because it comes up constantly on exams:

1. Reverse transcriptase (carried inside the virion) converts the ssRNA genome into dsDNA. This RNA-to-DNA step is unique to retroviruses and is a key drug target. Nucleoside reverse transcriptase inhibitors like AZT (zidovudine) work here by acting as faulty building blocks that terminate the growing DNA chain.
2. Integrase inserts the newly made viral DNA into the host chromosome. The integrated form is now called a provirus. This integration is what makes retroviral infection permanent.
3. Proviral transcription uses the host's own RNA polymerase II, producing both new genomic RNA (for packaging into new virions) and mRNA (for translation into viral proteins like Gag, Pol, and Env).

---

Assembly and Release: Producing New Virions

After replication, viral components must be assembled into infectious particles and released to spread infection. The release mechanism has major implications for host cell survival and disease progression.

Assembly

• Self-assembly of capsid proteins around the viral genome occurs through spontaneous protein-protein interactions driven by thermodynamics. The capsid proteins are designed to fit together, much like puzzle pieces that snap into place without external energy input.
• Assembly location varies. Many DNA viruses assemble in the nucleus (where their genome was replicated), while most RNA viruses assemble in the cytoplasm.
• Scaffolding proteins may assist assembly in complex viruses (like herpesviruses), then are removed or degraded in the mature virion.

Release

• Lysis destroys the host cell, releasing many virions simultaneously. This is typical of non-enveloped viruses and bacteriophages (like phage T4, which encodes lysozyme to degrade the bacterial cell wall).
• Budding allows gradual release while the host cell survives temporarily. Enveloped viruses acquire their lipid envelope during this process.
• Release mechanism influences pathogenesis. Lytic release causes acute tissue damage, while budding enables chronic, persistent infections.

Enveloped Virus Budding

Budding is a multi-step process worth understanding in detail:

1. Viral glycoproteins are synthesized by host ribosomes, processed through the ER and Golgi, and inserted into a host membrane (plasma membrane, ER, or Golgi, depending on the virus).
2. The assembled nucleocapsid migrates to the membrane region containing viral glycoproteins.
3. The nucleocapsid pushes through the membrane, wrapping itself in a lipid bilayer studded with viral glycoproteins. This pinches off as a complete enveloped virion.

Viral glycoproteins embedded in the envelope serve two critical roles: they're essential for infectivity (they mediate attachment and entry into the next cell) and they're major targets of neutralizing antibodies from the host immune system.

Because budding doesn't immediately kill the cell, the host cell can continue producing virions over time. This contributes to persistent infections and gives the virus more opportunity to evade immune detection.

---

Complete Replication Cycles: Lytic vs. Lysogenic Pathways

Some viruses can switch between immediate replication and dormancy. Understanding these alternative life cycles explains phenomena like viral latency, lysogenic conversion, and reactivation diseases.

Lytic Cycle

The lytic cycle is a straight path from infection to host cell destruction:

1. Attachment and penetration proceed as described above.
2. Host shutoff occurs early. The phage degrades host DNA and redirects all cellular resources toward viral production.
3. Genome replication and protein synthesis produce hundreds of copies of the viral genome and structural proteins.
4. Assembly packages genomes into new capsids.
5. Lysis destroys the cell. In bacteriophages, viral enzymes like holin (which perforates the inner membrane) and endolysin (which degrades peptidoglycan) work together to burst the cell open, releasing progeny virions.

This cycle is characteristic of virulent phages (like T4) and many acute viral infections. It means rapid replication, rapid spread, and rapid immune detection.

Lysogenic Cycle

The lysogenic cycle takes a different path after penetration:

1. Instead of immediately replicating, the viral genome integrates into the host chromosome, forming a prophage (in bacteria) or a latent provirus (in eukaryotic cells).
2. No virion production occurs during lysogeny. The viral genome is replicated passively every time the host cell divides, so every daughter cell carries the prophage.
3. A repressor protein (like lambda phage's CI repressor) keeps the lytic genes silenced. As long as the repressor is active, the virus stays dormant.
4. Induction triggers such as UV damage, chemical stress, or immune suppression can inactivate the repressor, reactivating the lytic cycle. This explains diseases like shingles, where varicella-zoster virus (VZV) reactivates from latency in sensory neurons years after the initial chickenpox infection.

Lysogenic conversion is a medically significant consequence of lysogeny. When a prophage carries genes that alter the host bacterium's phenotype, it can make a previously harmless bacterium pathogenic. The classic example: Corynebacterium diphtheriae only produces diphtheria toxin when it carries the tox gene from a lysogenic beta-phage. Without the prophage, the bacterium doesn't cause diphtheria. Other examples include the Shiga toxin in E. coli O157:H7 and cholera toxin in Vibrio cholerae (encoded by the CTXφ phage).

Temperate phages can follow either the lytic or lysogenic pathway. Virulent phages are lytic only and cannot integrate.

---

Quick Reference Table

---

Self-Check Questions

1. Which two stages of viral replication are most affected by whether a virus is enveloped or non-enveloped, and how do the mechanisms differ?

2. A virus integrates its genome into the host chromosome and remains dormant for years before reactivating. Is this virus following a lytic cycle, lysogenic cycle, or retroviral replication? How would you distinguish between the latter two? (Hint: think about what type of nucleic acid the original genome was.)

3. Compare and contrast the release mechanisms of bacteriophage T4 and HIV. How does each mechanism affect the host cell, and what does this predict about disease progression?

4. An antiviral drug blocks reverse transcriptase. Which type of virus would this drug be effective against, and at which stage of replication does it act? Could this drug work against influenza? Why or why not?

5. If an FRQ asks you to explain why lysogenic conversion is medically significant, which bacterial diseases would serve as your best examples, and what molecular event makes each bacterium pathogenic?